|Articles|May 20, 2021
Use of a MAbPac RP capillary column to monitor glycosylation site occupancy in therapeutics
Author(s)Thermo Fisher Scientific
A new approach using the novel, easy-to-connect Thermo Scientific MAbPac RP capillary column for determining glycosylation site occupancy of therapeutic antibodies from the analysis of their tryptic digest.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
2
How Mitigation and Maintenance Protect Against Future Risk
3
New Cord Blood Stem Cell Approval Alters Biopharma Manufacturing Priorities
4
Behind the Headlines Episode 29: 2025 Year in Review
5
